Seattle startup Cyrus inks protein-design deal with immune biotech Selecta worth up to $1.5 billion
Cyrus Biotechnology has several drug discovery and development partnerships and also markets Cyrus Bench, a software platform for protein engineering. (Cyrus photo) Seattle-based Cyrus Biotechnology is entering into a protein engineering collaboration with Boston-based Selecta Biosciences that could raise up to $ 1.5 billion for the University of Washington spinout. The partnership will support the … Read more
